Skip to main content
Clinical Trials/CTRI/2025/02/080478
CTRI/2025/02/080478Not yet recruitingNot Applicable

Smart at home screening and monitoring of Anemia and hypertension among antenatal mothers

Saveetha institute of medical and technical science1 site in 1 country100 target enrollmentStarted: February 25, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Determining the efficacy of Smartphone Application and non user

Study Overview

Brief Summary

Anemia and hypertension are common pregnancy-related conditions that can significantly impact both maternal and fetal health. Anemia, characterized by low red blood cell or hemoglobin levels, can lead to fatigue, weakness, and complications such as preterm birth or low birth weight if untreated. Hypertension, which includes gestational hypertension and preeclampsia, poses risks like organ damage and preterm birth, requiring vigilant monitoring and management. Gestational hypertension typically resolves after childbirth, while preeclampsia demands closer attention.

Effective management of these conditions through routine prenatal care is essential for preventing complications. Monitoring hemoglobin, ferritin levels, and blood pressure, alongside appropriate interventions like iron supplementation, dietary changes, and lifestyle adjustments, helps ensure better maternal and fetal outcomes. In some cases, medications may be prescribed for hypertension management.

This invention introduces a smartphone application-based point of care system designed to monitor and manage anemia and hypertension among antenatal mothers in real time. By providing healthcare providers with a platform for regular health assessments, the app enables early detection and timely interventions, reducing risks for both the mother and baby. This technology can particularly benefit underserved populations by enhancing access to care and improving prenatal health outcomes, offering a modern approach to managing these critical pregnancy conditions.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Hb less than 10 gm/dl Gestational hypertension Chronic hypertension Irrespective of gestational age.

Exclusion Criteria

  • Ectopic pregnancy molar pregnancy placenta previa Bleeding disorder Liver disorder Renal disorder.

Outcomes

Primary Outcomes

Determining the efficacy of Smartphone Application and non user

Time Frame: 8 weeks

Secondary Outcomes

  • Determining the maternal & fetal morbidity & mortality among the smart phone application user & non user(During delivery- approximate 37 weeks of gestation)

Investigators

Sponsor
Saveetha institute of medical and technical science
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Soniya

Saveetha institute of medical and technical science

Study Sites (1)

Loading locations...

Similar Trials